1000+ types of tissue microarray

TISSUE ARRAYS

CR245

Cervix cancer tissue array with matched adjacent cervix tissue, including pathology grade, TNM and clinical stage, 12 cases/24 cores

Zoom

CR245

Cores

Cases

Row number

Column number

Core Diameter(mm)

2.0

Thickness(µm)

5.0

Tissue Array Type

FFPE

Species

Human

QA/QC

H&E and IHC confirmed

Applications

Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.

Notes

1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better.

2.Bake the slides for 60 minutes at 65℃ before the experiment.

3.Please choose a gentle repair method to avoid tissue detachment.

Legend:

Ute

-Uterine cervix

AT (*)

Malignant (I)

Malignant (IB)

Malignant (II)

Malignant (IIA)

Malignant (IIB)

Malignant (IIIB)

TISSUE ARRAYS CR245

	1	2	3	4	5	6
A	UTE	UTE	UTE	UTE	UTE	UTE
B	UTE	UTE	UTE	UTE	UTE	UTE
C	UTE	UTE	UTE	UTE	UTE	UTE
D	UTE	UTE	UTE	UTE	UTE	UTE

Pos	No	Age	Sex	Organ_Anatomic_Site	Pathology_diagnosis	Grade	TNM	Stage	Type
A1	1	58	F	Uterine cervix	Squamous cell carcinoma	3	T2aN0M0	IIA	Malignant
A2	2	58	F	Uterine cervix	Cancer adjacent tissue (cervical canals tissue with adenomatosis)	*	*	*	AT
A3	3	40	F	Uterine cervix	Squamous cell carcinoma (chronic inflammation of cervical canals)	*	T1bN0M0	IB	Malignant
A4	4	40	F	Uterine cervix	Cancer adjacent tissue (cervix tissue)	*	*	*	AT
A5	5	28	F	Uterine cervix	Squamous cell carcinoma	1	T1bN0M0	IB	Malignant
A6	6	28	F	Uterine cervix	Cancer adjacent tissue (cervix tissue)	*	*	*	AT
B1	7	53	F	Uterine cervix	Squamous cell carcinoma	3	T2N0M0	II	Malignant
B2	8	53	F	Uterine cervix	Cancer adjacent tissue (chronic inflammation of cervical mucosa)	*	*	*	AT
B3	9	55	F	Uterine cervix	Squamous cell carcinoma	1	T2aN0M0	IIA	Malignant
B4	10	55	F	Uterine cervix	Cancer adjacent tissue (cervix tissue)	*	*	*	AT
B5	11	39	F	Uterine cervix	Squamous cell carcinoma	2	T1N0M0	I	Malignant
B6	12	39	F	Uterine cervix	Cancer adjacent tissue (cervix tissue)	*	*	*	AT
C1	13	39	F	Uterine cervix	Squamous cell carcinoma	3	T2bN0M0	IIB	Malignant
C2	14	39	F	Uterine cervix	Cancer adjacent tissue (chronic inflammation of cervical mucosa)	*	*	*	AT
C3	15	40	F	Uterine cervix	Squamous cell carcinoma	3	T1bN0M0	IB	Malignant
C4	16	40	F	Uterine cervix	Cancer adjacent tissue (chronic inflammation of cervical mucosa)	*	*	*	AT
C5	17	42	F	Uterine cervix	Squamous cell carcinoma	3	T2aN0M0	IIA	Malignant
C6	18	42	F	Uterine cervix	Cancer adjacent tissue (cervix tissue)	*	*	*	AT
D1	19	54	F	Uterine cervix	Squamous cell carcinoma	3	T1N0M0	I	Malignant
D2	20	54	F	Uterine cervix	Cancer adjacent tissue (cervix tissue)	*	*	*	AT
D3	21	45	F	Uterine cervix	Squamous cell carcinoma	3	T1N1M0	IIIB	Malignant
D4	22	45	F	Uterine cervix	Cancer adjacent tissue (chronic inflammation of cervical mucosa)	*	*	*	AT
D5	23	57	F	Uterine cervix	Adenocarcinoma	1	T2N1M0	IIIB	Malignant
D6	24	57	F	Uterine cervix	Cancer adjacent tissue (chronic inflammation of cervical mucosa with moderate epithelial hyperplasia)	*	*	*	AT
Tissue Marker